作者: Sudipta Sinnya , Fiona O. Zwald , Oscar R. Colegio
DOI: 10.1097/TXD.0000000000000535
关键词: Intensive care medicine 、 Melanoma 、 Surgery 、 Organ transplantation 、 Merkel cell carcinoma 、 Immunosuppression 、 Lymphoproliferative disorders 、 Medicine 、 Skin cancer 、 Basal cell carcinoma 、 Solid organ
摘要: The International Transplant Skin Cancer Collaborative (ITSCC) is an organization comprising of physicians; transplant surgeons and basic science research scientists dedicated in providing optimal care ongoing advancements solid organ recipients to improve patient outcome quality life. As medical advances occur, it anticipated that the sheer number transplantations occurring worldwide will continue increase. long-term medication associated immunosuppression improves graft survival, but as a consequence, these individuals become increasingly susceptible various cutaneous malignancies, lymphoproliferative disorders infections. Squamous cell carcinoma most frequently encountered skin cancer increases 65- 250-fold [Jensen et al., kidney heart different immunosuppressive therapy regimens. J Am Acad Dermatol. 1999;40:177-186; Lindelof Incidence 5356 patients following transplantation. Br 2000; 143:513-519]. However, rates basal carcinoma, Merkel melanoma also increase leading significant morbidity well mortality [Berg Otley. recipients: epidemiology, pathogenesis, management. 2002; 47:1-20]. In October 2014, its equivalent European counterpart, Care Organ Recipients Europe held 10th biennial meeting Essex, MA discuss clinical conundrums evolving pertinent field. This report provides synthesis all data presented at 4-day meeting.